Permits pharmacists to administer certain long-acting injectable drugs.

S 3676 permits pharmacists in New Jersey to administer specific long-acting injectable drugs for psychiatric conditions, which are FDA-approved medications designed to treat symptoms with a single dose lasting up to 24 weeks. Pharmacists must meet certification requirements set by the New Jersey State Board of Pharmacy and the State Board of Medical Examiners, and administration requires a prescription from an authorized prescriber. The bill defines "long-acting injectable drugs" as those treating psychiatric disorders, excluding vaccines or non-psychiatric medications. This change expands pharmacists' scope of practice to include these specific drugs under regulated conditions, without altering existing prescription requirements.